Search results for "Opera"

showing 10 items of 8665 documents

Second St. Gallen European Organisation for Research and Treatment of Cancer Gastrointestinal Cancer Conference: consensus recommendations on controv…

2016

Contains fulltext : 171468pub.pdf (Publisher’s version ) (Open Access) Primary treatment of rectal cancer was the focus of the second St. Gallen European Organisation for Research and Treatment of Cancer (EORTC) Gastrointestinal Cancer Conference. In the context of the conference, a multidisciplinary international expert panel discussed and voted on controversial issues which could not be easily answered using published evidence. Main topics included optimal pretherapeutic imaging, indication and type of neoadjuvant treatment, and the treatment strategies in advanced tumours. Here we report the key recommendations and summarise the related evidence. The treatment strategy for localised rect…

Cancer ResearchStagingColorectal cancermedicine.medical_treatmentNeoplasias Gastrointestinais030230 surgerySYNCHRONOUS LIVER METASTASESImagingCOLORECTAL-CANCER0302 clinical medicineADJUVANT CHEMOTHERAPYTumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]SHORT-COURSE RADIOTHERAPYRectal cancerNeoadjuvant therapyGastrointestinal NeoplasmsRectal Neoplasms/drug therapyCombination chemotherapyChemoradiotherapyCombined Modality TherapyTotal mesorectal excisionNeoadjuvant TherapyEuropeNeoplasias do Recto/quimioterapiaOncology030220 oncology & carcinogenesisMEDIAN FOLLOW-UPLife Sciences & BiomedicineDiagnostic Imagingmedicine.medical_specialtyAntineoplastic AgentsLOCAL RECURRENCERisk AssessmentCOURSE PREOPERATIVE RADIOTHERAPY03 medical and health sciencesmedicineHumansGastrointestinal cancerOncology & CarcinogenesisRadiochemotherapyNeoplasm StagingScience & TechnologyRadiotherapyRectal Neoplasmsbusiness.industryGeneral surgeryTOTAL MESORECTAL EXCISIONCancerRANDOMIZED PHASE-IIImedicine.diseaseSurgeryRadiation therapySurgerybusiness1112 Oncology And CarcinogenesisChemoradiotherapyPOSTOPERATIVE CHEMORADIOTHERAPY
researchProduct

Sexual, bladder and bowel function following different minimally invasive techniques of radical hysterectomy in patients with early-stage cervical ca…

2021

Abstract Purpose Despite the establishment of radical surgery for therapy of cervical cancer, data on quality of life and patient-reported outcomes are scarce. The aim of this retrospective cohort study was to evaluate bladder, bowel and sexual function in women who underwent minimally invasive surgery for early-stage cervical cancer. Methods From 2007–2013, 261 women underwent laparoscopically assisted radical vaginal hysterectomy (LARVH = 45), vaginally assisted laparoscopic or robotic radical hysterectomy (VALRRH = 61) or laparoscopic total mesometrial resection (TMMR = 25) and 131 of them completed the validated German version of the Australian Pelvic Floor Questionnaire (PFQ). Results …

Cancer ResearchUrinary Incontinence StressUrinary incontinenceUterine Cervical NeoplasmsUrinary incontinence0302 clinical medicinePostoperative ComplicationsRobotic Surgical ProceduresSurveys and QuestionnairesHysterectomy VaginalPostoperative PeriodCervical cancerIntestinal Disease030219 obstetrics & reproductive medicinePelvic floorUrinary Bladder DiseasesGeneral MedicineOrgan SizeMiddle Agedmedicine.anatomical_structureDyspareuniaOncology030220 oncology & carcinogenesisVaginaVaginaFemalemedicine.symptomResearch ArticleQuality of lifeAdultmedicine.medical_specialtySexual functionHysterectomy03 medical and health sciencesPelvic floor dysfunctionMinimally invasive surgerymedicineHumansPatient Reported Outcome MeasuresRadical surgeryRadical HysterectomyPelvic floor functionAgedNeoplasm StagingRetrospective Studies...business.industryUrinary Bladder Overactivemedicine.diseaseSurgeryIntestinal DiseasesSexual Dysfunction PhysiologicalCase-Control StudiesCervical cancerLaparoscopyPostoperative ComplicationSexual functionbusinessConstipationClinical & Translational Oncology
researchProduct

Cytomegalovirus DNAemia in patients with de novo acute myeloid leukemia undergoing cytotoxic chemotherapy

2019

There is evidence suggesting that cytomegalovirus (CMV) reactivation following allogeneic hematopoietic stem cell transplantation (allo-HSCT) may be associated with a lower relapse incidence in acu...

Cancer Researchbusiness.industrymedicine.medical_treatmentIncidence (epidemiology)De novo acuteCongenital cytomegalovirus infectionvirus diseasesMyeloid leukemiaHematologyHematopoietic stem cell transplantationCytotoxic chemotherapymedicine.disease03 medical and health sciencessurgical procedures operative0302 clinical medicineOncology030220 oncology & carcinogenesisCancer researchMedicineIn patientbusiness030215 immunologyLeukemia & Lymphoma
researchProduct

Indocyanine Green to Assess Vascularity of Ileal Conduit Anastomosis During Pelvic Exenteration for Recurrent/Persistent Gynecological Cancer: A Pilo…

2021

IntroductionPelvic exenteration performed for recurrent/persistent gynecological malignancies has been associated with urological short- and long-term morbidity due to altered vascularization of tissues for previous radiotherapy. The aims of the present study were to describe the use of intravenous indocyanine green (ICG) to assess vascularity of urinary diversion (UD) after pelvic exenteration for gynecologic cancers, to evaluate the feasibility and safety of this technique, and to assess the postoperative complications.MethodsProspective, observational, single-center, pilot study including consecutive patients undergoing anterior or total pelvic exenteration due to persistent/recurrent gy…

Cancer Researchmajor postoperative complicationsNeoplasms. Tumors. Oncology. Including cancer and carcinogensanastomosisgynecological canceranastomosimajor postoperative complicationeye diseasespelvic exenteration (PE)body regionsileal conduit diversionSettore MED/40 - GINECOLOGIA E OSTETRICIAOncologyindocyanine green (ICG)anastomosis; gynecological cancer; ileal conduit diversion; indocyanine green (ICG); major postoperative complications; pelvic exenteration (PE)RC254-282Original ResearchFrontiers in Oncology
researchProduct

Impact of BMI on Preoperative Axillary Ultrasound Assessment in Patients With Early Breast Cancer

2020

Background The accuracy of axillary ultrasound (AUS) with fine-needle aspiration with varying patient body mass index (BMI) is still unclear. The aim of our study was to evaluate whether the US features of axillary lymph nodes changes with BMI of patients. Patients and methods A retrospective review was performed involving 144 out of 270 patients with early breast cancer who underwent breast surgery with sentinel lymph node biopsy. Diagnostic efficacy of AUS in preoperative axillary nodal staging was assessed in relation to BMI. Results Negative predictive values of AUS for the overweight and obese groups were statistically significantly lower compared to the normal/underweight group (p=0.0…

Cancer Researchmedicine.medical_specialtyAxillary lymph nodesBreast surgerymedicine.medical_treatmentSentinel lymph nodeBreast NeoplasmsOverweightBody Mass Indexaxillary ultrasoundBMIBreast cancerbreast cancerBiopsymedicineHumansUltrasonographymedicine.diagnostic_testpredictive valuebusiness.industryGeneral Medicinemedicine.diseasemedicine.anatomical_structureOncologyCohortAxillaPreoperative PeriodFemaleRadiologymedicine.symptombusinessBody mass index
researchProduct

Short-course radiotherapy followed by chemotherapy before TME in locally advanced rectal cancer: The randomized RAPIDO trial

2020

4006 Background: Local control in locally advanced rectal cancer (LARC) has improved. However, systemic relapses remain high even with postoperative chemotherapy, possibly due to low compliance. Short-course radiotherapy (SCRT) followed by delayed surgery with, in the waiting period, chemotherapy, may lead to better compliance, downstaging and fewer distant metastases. The main objective of the international multicenter phase III RAPIDO trial is to decrease Disease-related Treatment Failure (DrTF), defined as locoregional failure, distant metastasis, a new primary colon tumor or treatment-related death, by reducing the risk of systemic relapse without compromising local control. Methods: M…

Cancer Researchmedicine.medical_specialtyChemotherapyPostoperative chemotherapyColorectal cancerbusiness.industrymedicine.medical_treatmentLocally advancedmedicine.diseaseSurgery03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesismedicinebusiness030215 immunologyShort course radiotherapy
researchProduct

Follow-up of patients with colonic polyps containing severe atypia and invasive carcinoma. Compliance, recurrence, and survival

1988

Between January 1975 and December 1984 1769 polyps were endoscopically removed from 1219 patients. Eight percent of these patients had polyps containing severe atypia and 5.0% had polyps containing invasive cancer. A close postoperative surveillance program was followed by only a few patients, but compliance improved with longer follow-up intervals. Metachronous polyps were observed with similar frequency in patients with benign polyps (34.8%) and those with polyps containing severe atypia (23.8%) or cancer (41.7%). Patients in whom malignant polyps were endoscopically removed had a 5-year survival rate of 84.3% that did not differ from that of patients' whose polyps contained severe atypia…

Cancer Researchmedicine.medical_specialtyColonic PolypsGastroenterologyActuarial AnalysisInternal medicineotorhinolaryngologic diseasesmedicineAtypiaCarcinomaHumansNeoplasm InvasivenessPatient complianceneoplasmsSurvival rateAgedRetrospective StudiesInvasive carcinomaEpitheliomabusiness.industryCarcinomaCancerEndoscopypathological conditions signs and symptomsMiddle Agedmedicine.diseasedigestive system diseasesBenign polypsSurgerysurgical procedures operativeOncologyPopulation SurveillancePatient ComplianceNeoplasm Recurrence LocalbusinessFollow-Up StudiesCancer
researchProduct

In the literature: April 2017

2017

The full publication in Lancet Oncology of the Stockholm III trial helps us to understand that short-course radiotherapy in patients with localised rectal cancer could also be followed by delayed surgery.1 During more than 14 years, more than 800 patients with rectal cancer not showing unresectable features were randomised in a two-arm versus three-arm study with a non-inferiority design. Patients could be randomised to short-course radiotherapy (5×5 Gy) and immediate (within a week) versus delayed (4–8 weeks) surgery. In the three-arm randomisation patients could also be allocated to a long course of concurrent chemoradiation (25×2 Gy), with surgery performed 6–8 weeks thereafter. Time to …

Cancer Researchmedicine.medical_specialtyColorectal cancerbusiness.industrymedicine.medical_treatmentPostoperative complicationConcurrent chemoradiationNewsmedicine.diseaseSurgeryRadiation therapyOncologyLiteratureClinical endpointmedicineDelayed surgeryIn patient1506businessESMO Open
researchProduct

EPCT-15. RAPID EPIGENOMIC CLASSIFICATION OF BRAIN TUMORS ENABLES INTRAOPERATIVE NEUROSURGICAL RISK MODULATION

2021

Abstract Background Clear identification of tumor subtype is the main predictor of patient outcome and ultimately what is considered an adequate level of surgical risk. At brain tumor resection, imaging modalities and intraoperative histology often give an ambigious diagnosis, complicating intraoperative surgical decision-making. Here, we report a nanopore DNA methylation analysis (NDMA) sequencing approach combined with machine learning for classification of tumor entities that could be used intraoperatively. Methods We analyzed 50 biopsies obtained from biobanked tissue (43, prospective) or sampled at surgery (7, intraoperative) from 20 female and 30 male patients with a median age of 8 y…

Cancer Researchmedicine.medical_specialtyIntra operativebusiness.industryTranslational/Early Phase Clinical TrialsTumor excisionOncologymedicineAcademicSubjects/MED00300AcademicSubjects/MED00310Neurology (clinical)RadiologyOperative riskbusinessEpigenomicsNeuro-Oncology
researchProduct

Preoperative CT-Based Deep Learning Model for Predicting Risk Stratification in Patients With Gastrointestinal Stromal Tumors.

2021

ObjectiveTo develop and evaluate a deep learning model (DLM) for predicting the risk stratification of gastrointestinal stromal tumors (GISTs).MethodsPreoperative contrast-enhanced CT images of 733 patients with GISTs were retrospectively obtained from two centers between January 2011 and June 2020. The datasets were split into training (n = 241), testing (n = 104), and external validation cohorts (n = 388). A DLM for predicting the risk stratification of GISTs was developed using a convolutional neural network and evaluated in the testing and external validation cohorts. The performance of the DLM was compared with that of radiomics model by using the area under the receiver operating char…

Cancer Researchmedicine.medical_specialtyReceiver operating characteristicbusiness.industryDeep learningClass activation mappingNeoplasms. Tumors. Oncology. Including cancer and carcinogensrisk assessmentdeep learningX-ray computedtomographyConfidence intervalprediction modelgastrointestinal stromal tumorsOncologyRisk stratificationCohortMedicineIn patientRadiologyArtificial intelligencebusinessRisk assessmentRC254-282Original ResearchFrontiers in oncology
researchProduct